Associated Papers
Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers.
Peng SB et al.
Cancer Cell, 2015
Non-hodgkin lymphoma in a patient with cardiofaciocutaneous syndrome.
Ohtake A et al.
Journal of Pediatric Hematology/oncology, 2011
BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins.
Friday BB et al.
Cancer Research, 2008
Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
Ikenoue T et al.
Cancer Research, 2004
BRAF mutations in non-Hodgkin's lymphoma.
Lee JW et al.
British Journal of Cancer, 2003
Select a paper to view details